🇨🇦 Canada Country × Condition
malignant solid neoplasm Clinical Trials in Canada
Active clinical trials for malignant solid neoplasm with research sites in Canada. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 3, Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇨🇦 Canada
Active Trials in Canada (3)
NCT02402244
Recruiting
Project: Every Child for Younger Patients With Cancer
Enrollment
75,000 pts
Country
🇨🇦 Canada
Children's Oncology Group
View Trial → NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Enrollment
60 pts
Country
🇨🇦 Canada
Children's Oncology Group
View Trial → NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Enrollment
300 pts
Country
🇨🇦 Canada
National Cancer Institute (NCI)
View Trial → Frequently Asked Questions
How many malignant solid neoplasm clinical trials are active in Canada?
There are currently 3 active clinical trials for malignant solid neoplasm with sites in Canada, of which 3 are actively recruiting patients.
How can I join a malignant solid neoplasm clinical trial in Canada?
To join a malignant solid neoplasm clinical trial in Canada, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Canada directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are malignant solid neoplasm trials in Canada?
Active malignant solid neoplasm trials in Canada span Phase 3, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.